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Activation of the Ca2+ Release Channel of Skeletal Muscle Sarcoplasmic
Reticulum by Palmitoyl Carnitine
Roque El-Hayek, Carmen Valdivia, Hector H. Valdivia, Kirk Hogan,* and Roberto Coronado
Departments of Physiology and *Anesthesiology, University of Wisconsin School of Medicine, Madison, Wisconsin 53706 USA
ABSTRACT Studies of [H]ryanodine binding, 45Ca2' efflux, and single channel recordings in planar bilayers indicated that
the fatty acid metabolite palmitoyl carnitine produced a direct stimulation of the Ca2+ release channel (ryanodine receptor) of
rabbit and pig skeletal muscle junctional sarcoplasmic reticulum. At a concentration of 50 MM, palmitoyl carnitine (a) stimulated
PH]ryanodine binding 1.6-fold in a competitive manner at all pCa in the range 6 to 3; (b) released approximately 65% (30 nmol)
of passively loaded 45Ca2+/mg protein; and (c) increased 7-fold the open probability of Ca2+ release channels incorporated into
planar bilayers. Neither carnitine nor palmitic acid could reproduce the effect of palmitoyl carnitine on [3H]ryanodine binding,
45Ca2+ release, or channel open probability. 45Ca2+ release was induced by several long-chain acyl carnitines (C14, C16, C18)
and acyl coenzymeA derivatives (C12, C14, C16), but not by the short-chain derivative C8 or by free saturated fatty acids of chain
length C8 to C18, at room temperature or 360C. This newly identified interaction of esterified fatty acids and ryanodine receptors
may represent a pathway by which metabolism of skeletal muscle could influence intracellular Ca2+ and may be responsible
for the pathophysiology of disorders of 3-oxidation such as carnitine palmitoyl transferase 11 deficiency.
INTRODUCTION
Lipids, fatty acids, and related metabolites participate in sig-
nal transduction pathways that stimulate the release of Ca2,
from intracellular stores in a variety of tissues.A well-known
cascade is initiated by the breakdown of phosphatidylinositol
bisphosphate into inositol 1,4,5-trisphosphate and diacyl-
glycerol (Berridge and Irvine, 1989). Other Ca2+-mobilizing
lipid metabolites including arachidonic acid, unsaturated
fatty acids, or sphingosine derivatives mobilize Ca2, from
intracellular stores but operate independently of the inositol
1,4,5-trisphosphate signaling pathway (Wolf et al., 1986;
Chow and Jondal, 1990; Ghosh et al., 1990). Muscle and
brain cells have intracellular Ca2, channels sensitive to caf-
feine and to the muscle-paralyzing alkaloid ryanodine
(McPherson et al., 1991). In skeletal and cardiac muscle,
ryanodine receptors are abundant in the junctional sarco-
plasmic reticulum (Block et al., 1988) and release Ca2' dur-
ing excitation-contraction coupling in response to cell mem-
brane depolarization (Valdivia et al., 1992b). Ryanodine
receptors are activated by Ca2' at physiological concentra-
tions and are modulated by a variety of ligands that affect
Ca2+-induced Ca2' release such as Mg2+, adenine nucle-
otides, and caffeine (Ogawa and Ebashi, 1976; Meissner,
1984; Sumbilla and Inesi, 1987; Calviello and Chiesi, 1989;
Valdivia et al., 1992a). This modulation of ryanodine re-
ceptors by intracellular ligands has been critical for under-
standing the deregulation of intracellular Ca2, that occurs in
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metabolic diseases of skeletal muscle such as malignant hy-
perthermia (Fujii et al., 1991; Valdivia et al., 1991b).
The intracellular fatty acid metabolite palmitoyl carnitine
is a major energy donor for ,3-oxidation, and its transport into
the mitochondrial matrix is facilitated by camitine palmitoyl
transferase II (Woeltje et al., 1990). A possible role of palm-
itoyl carnitine in the control of intracellular Ca2+ was sug-
gested by studies of the autosomal recessive disorder of en-
ergy metabolism known as palmitoyl transferase II
deficiency (DiMauro and DiMauro, 1973; Hoppel et al.,
1980; Demaugre et al., 1988; Haeckel et al., 1990). This is
a disorder primarily affecting skeletal muscle and is char-
acterized by the elevation of cellular and plasma levels of
palmitoyl carnitine due to a low activity of the mitochondrial
transport enzyme (DiMauro and DiMauro, 1973; Demaugre
et al., 1988; Haeckel et al., 1990). A molecular defect in
palmitoyl transferase II linked to this disorder was recently
described (Taroni et al., 1992). Individuals with palmitoyl
transferase II deficiency experience recurrent muscle pains,
paralysis, muscle necrosis, and myoglobinuria triggered by
exercise, cold, or fever (Demaugre et al., 1988). Since muscle
wasting is prominent in several muscle disorders and can
occur by Ca2, toxicity upon elevation of myoplasmic Ca2,
(Martonosi, 1989), we investigated the possibility that palm-
itoyl carnitine and related metabolites changed the Ca2, per-
meability of sarcoplasmic reticulum, the primary Ca2, stor-
age site of skeletal muscle cells. Here we show that palmitoyl
carnitine and related long-chain esterified fatty acids caused
a dramatic increase in the Ca2, permeability of skeletal mus-
cle sarcoplasmic reticulum by a direct activation of the Ca2+
release channel formed by the ryanodine receptor. We thus
propose that a severe accumulation of palmitoyl carnitine in
skeletal muscle, such as that occurring in carnitine palmitoyl
transferase II deficiency, leads to an increase of myoplasmic
Ca2+, which in turn triggers muscle destruction.
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MATERIALS AND METHODS Rapid filtration of extravesicular '5Ca2+ passively
Preparation of junctional sarcoplasmic reticulum loaded into sarcoplasmic reticulum vesicles
Pig soleus muscle or rabbit back and leg white muscle were dissected from
anesthetized animals following procedures approved by the University of
Wisconsin Research Animal Resources Committee. Soleus muscle was cho-
sen for its ease of dissection and minimal animal bleeding. Preparations
occasionally made from pig paraspinous (deep back) muscles yielded a
similar receptor density and similar pharmacological properties. Heavy sar-
coplasmic reticulum was prepared in both cases as described for rabbit
skeletal muscle (Valdivia et al., 1992a). Sucrose density-purified mem-
branes sedimenting between 35% and 40% sucrose were used in all ex-
periments. Membranes were stored in 0.3 M sucrose, 0.1 M KCI, and 5 mM
sodium N'-bis-2-ethanesulfonic acid (Na-PIPES) (pH 6.8) at -80°C.
Binding of [3H]ryanodine to sarcoplasmic
reticulum
Assays were carried out as described (Valdivia et al., 1991a,b). Duplicate
samples (40 p.g protein each) were incubated for 120 min at 360C in 0.1 ml
of 7 nM [3H]ryanodine, 0.2 M KCI, 10mM Na-PIPES (pH 7.2), and 1 mM
EGTA plus CaCl2 to set free Ca2, in the range of pCa 7 to 3. Free Ca2, was
calculated by a computer program that used the stability constants of Fabiato
(1988). Samples were filtered onto glass fiber filters (Whatman GF/B or
GF/C) and washed twice with 5 ml of cold distilled water. The specific
binding was calculated as the difference between the binding in the absence
(total binding) and in the presence (nonspecific binding) of 10 p.M cold
ryanodine. Specific [3H]ryanodine binding in the rabbit and porcine prep-
arations under optimal conditions (1 M KCl, 100 p.M Ca2+, 5 mMATP, 100
nM [3H]ryanodine, 10 mM Na-PIPES, pH 8.5) were 15.5 ± 2.3 and 11.6
± 2 pmol/mg protein, respectively. Control [3H]ryanodine binding without
metabolite was always made in the presence of an equal concentration of
methanol, typically 1% (v/v). Methanol had no effect on [3H]ryanodine
binding up to a concentration of 5% (v/v). Protein concentration was de-
termined by the Bradford method with a Bio-Rad kit (Richmond, CA).
45Ca2+ loading of sarcoplasmic reticulum vesicles
Loading of "5Ca2+ was described previously (Valdivia et al., 1992a). Sam-
ples of porcine or rabbit sarcoplasmic reticulum (-2.5 mg protein) were
incubated in 1 ml of 5 mM 45CaCI2 (-7500 cpm/nmol), 150 mM KCl, and
50mM MES (2-[N-morpholino]ethanesulfonic acid) titrated with Tris to pH
7.2 at room temperature for 2 to 3 h. The total 45Ca2+ content averaged 58
± 11 nmol/mg protein in seven preparations from rabbit and 32 ± 6
nmol/mg protein in four preparations from porcine sarcoplasmic reticulum.
45Ca2+ content was determined by a 50-fold dilution of 20 ,ul of 45Ca2+-
loaded sarcoplasmic reticulum into 150 mM KCl, 5 mM MgCl2, 1 mM
EGTA, 10 p.M ruthenium red, and 50 mM MES-Tris (pH 7.5) followed by
a rinse of filters with 3 ml of the same solution. Background 45Ca2+ was
evaluated in each experiment and was subtracted from each filter. To meas-
ure 45Ca2' background, duplicate samples were diluted 50-fold in the
"Mg2+" solution described below containing 10 p.M Ca2+ ionophore
A23187. Background 45Ca2, was 51 nmol 45Ca2+/filter/mg protein. Release
was initiated by dilution of 20 p.l of the 45Ca2+-loaded sarcoplasmic retic-
ulum (-50 ,ug protein) into 1 ml of "Mg2+" solution consisting of 5 mM
MgCl2, 1 mM EGTA, 150 mM KCI, and 50 mM MES-Tris (pH 7.2) (see
Figs. 4B, SB, 7B, and 9). Metabolites were added to "Mg2+" solution from
stocks prepared in methanol. The same concentration of methanol (:1%)
was always added to controls. Methanol had no effect on 45Ca2+ efflux up
to a concentration of 5% (v/v). The diluted sarcoplasmic reticulum was
incubated for 5 s and spread onto a 0.8-p.m nitrocellulose filter (Millipore,
Danvers, MA). Filters were rinsed under a mild vacuum with 3 ml of 150
mM KCI, 5 mM MgCl2, 1 mM EGTA, 10 p.M ruthenium red, and 50 mM
MES-Tris (pH 7.5). Controls were made to ensure that palmitoyl carmitine
did not cause loss of sarcoplasmic reticulum vesicles from nitrocellulose
filters.
Rapid filtration experiments (see Figs. 4A and 8) were performed as de-
scribed previously (Valdivia et al., 1992a) using a Dupont apparatus (Bi-
ologic Instruments, Echirolles, France). Rabbit sarcoplasmic reticulum pas-
sively loaded with 5 mM 45Ca2+ as described above was used in all
experiments. Prior to rapid filtration, the extravesicular 45CaC12 was lowered
to approximately 7 nM by dilution of 20 ,ul of the 45Ca2_-loaded material
(50 ,jg protein) into 1 ml of 5 mM MgCl2, 1 mM EGTA, 150 mM KCl, 50
mM MES-Tris (pH 7.5). The diluted sarcoplasmic reticulum was immedi-
ately spread onto the surface of a wet 0.8-,um nitrocellulose filter (Millipore,
Danvers, MA), and the rapid filtration was then executed. Filtrations were
carried out at constant rate of 4 ml/s. In Fig. 8, the filtration solution was
labeled Mg2, (described above), PC + Mg2+ (5 mM MgCl2, 1 mM EGTA,
50 ,uM palmitoyl carnitine, 150 mM KCl, 50 mM MES-Tris, pH 7.5); Ca2,
(6.25mM EGTA, 6.23mM CaCl2, 150mM KCI, 50mM MES-Tris, pH 7.5);
orATP (6.25mM EGTA, 6.23 mM CaCl2, 1 mM ATP, 150mM KC1, 50mM
MES-Tris, pH 7.5). The calculated free Ca2, of the "Mg2+" solution was 0.2
nM (assuming a contaminant CaCl2 of 3.5 ,uM) and that of the "Ca2+"
solution was 10 ,uM. Following rapid filtration, filters were rinsed under a
mild vacuum with 3 ml of 150 mM KCI, 5 mM MgCl2, 1 mM EGTA, 10
p.M ruthenium red, and 50 mM MES-Tris (pH 7.5).
Reversibility of palmitoyl carnitine stimulation of
[3H]ryanodine binding and "Ca2+ release
To establish whether the stimulation of [3H]ryanodine binding by palmitoyl
carnitine was reversible, 800 jig of rabbit sarcoplasmic reticulum was di-
luted into 2 ml of 0.2 M KCl, 1 mM EGTA, 1.25 mM CaCl2 (10 p.M free
Ca2,), and 10mM Na-PIPES (pH 7.2). The suspension was divided into two
samples and processed side by side. A control sample was incubated for 30
min at room temperature with S p.l of methanol (final concentration, 0.5%
v/v), whereas the test sample was incubated with S p.l of stock 10 mM
palmitoyl carnitine dissolved in methanol (final concentration, 50 p.M palm-
itoyl camitine). At the end of the incubation period, 200 ,l was removed
from each sample, and [3H]ryanodine binding assays were carried out as
described above in 0.1 ml of 7 nM [3H]ryanodine, 0.2M KCI, 1 mM EGTA,
1.25 mM CaCl2, and 10 mM Na-PIPES (pH 7.2) in the absence (control
sample) or presence (test sample) of 50 p.M palmitoyl carnitine. Binding
activities measured in duplicate in control and test samples averaged 0.46
± 0.1 and 0.95 ± 0.21 pmol/mg, respectively. The higher binding of the test
sample verified the stimulation by 50 p.M palmitoyl camitine. To remove
palmitoyl carnitine, the remaining control and test samples were centrifuged
at 10,000 rpm for 10 min in a benchtop centrifuge, the supernatant was
discarded, and the pellet was resuspended in 0.8 ml of 0.2 M KCI, 10 mM
Na-PIPES (pH 7.2). This centrifugation and resuspension was repeated three
times. Control and test samples washed in this manner were assayed for
[3H]ryanodine binding activity as described above. Following the wash,
binding activities of control and test samples were 0.39 ± 0.1 and 0.34 ±
0.09 pmollmg, respectively. The absence of a higher binding in the test
sample verified that the stimulation by 50 p.M palmitoyl carmitine was re-
versible. The loss of binding activity of the control sample following the
wash was due to a rundown and loss of protein during the wash cycles.
To establish whether the stimulation of 45Ca2' release by palmitoyl car-
nitine was reversible, samples were actively loaded with 45Ca2+ by the
incubation of -90 ,ug of rabbit sarcoplasmic reticulum in 100 ,ul of 150mM
K+-gluconate, 5 mM Mg2+-acetate, 100 p.M Ca2,-acetate, 1 mM MgATP,
and 20 mM MES-Tris (pH 6.8) for 3 min at 37°C. Release was initiated by
dilution into 1 ml of 150mM K+-gluconate, 5mM Mg2`-acetate, and 20mM
MES-Tris (pH 6.8) without (control) or with (test) 50 pLM palmitoyl car-
nitine. Diluted samples were immediately filtered and washed as described
above. 45Ca2+ retained in the sarcoplasmic reticulum samples was 56.5 ±
2 and 16 ± 1.1 nmol/mg, respectively, in control and test samples, each
repeated three times. The loss of 45Ca2, from the test samples reflected the
stimulation of 45Ca2+efflux by 50 p.M palmitoyl carnitine. Reversibility was
determined by the incubation of 800 ,ug of sarcoplasmic reticulum in 1 ml
of 150 mM K+-gluconate, 5 mM Mg2+-acetate, 20 mM MES-Tris (pH 6.8)
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without (control sample) or with (test sample) 50 ,uM palmitoyl carnitine
for 30 min at room temperature. Control and test samples were centrifuged
for 10 min at 10,000 rpm and resuspended by vortex in 2 ml of the same
buffer without palmitoyl carnitine. Centrifugation and resuspension was
repeated three times. Control and test samples washed in this manner were
assayed for 45Ca2, uptake as described above. At the end of the uptake
period, control and test samples were diluted 10-fold in K+-gluconate buffer
without palmitoyl camitine. Following the wash, 45Ca2+ uptake of control
and test samples were 86 ± 2 and 97 ± 10 nmollmg, respectively. The
absence of a difference in retained 45Ca2+ in control and test samples in-
dicated the reversibility of the stimulation by palmitoyl carnitine. The higher
uptake of both samples was likely due to a selective loss during the wash
cycles of light sarcoplasmic reticulum, which has a comparatively lower
internal volume than the heavier sarcoplasmic reticulum.
Planar bilayer recording of Ca2+ release channels
Planar bilayer formation and recording were described previously (Coro-
nado et al., 1992). Bilayers were composed of equal concentrations of brain
phosphatidylethanolamine and phosphatidylserine dissolved in decane (Al-
drich Chemical Co., Milwaukee, WI) at 20 mg/ml. Porcine sarcoplasmic
reticulum was used in all recordings. Protein (100 to 200 jig) was added to
the cis (cytosolic) solution composed of 250 mM CsCl and 10 mM N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid titrated with Tris to pH
7.2. The trans (lumenal) solution was the same, except that the CsCl was
50 mM. Recordings were routinely made at +20 mV, which is close to the
equilibrium potential for anionic channels in the sarcoplasmic reticulum
preparation (Coronado et al., 1992). Anion-selective channels were not
present in any of the recordings of this study. The contaminant-free Ca2+ of
the cis chamber was in the range of 1 to 3.6 ,uM and was measured by Ca2+
electrode. Recordings were filtered through a low-pass Bessel (Frequency
Devices, Haverhill, MA) at 1 kHz and digitized at 4 kHz. Metabolites were
added from stock solutions in methanol, except in the case of free camitine,
which was added in distilled water. A concentration of 1% (v/v) methanol,
the highest concentration present in any experiment, had no effect on open
channel probability.
Chemicals
Palmitoyl-D,L-carnitine chloride, palmitoyl coenzyme A (free acid),
L-carmitine hydrochloride, palmitic acid (sodium salt), other acyl carnitines,
acyl coenzyme A, and free fatty acids (octanoyl C8:0; lauroyl C12:0; myris-
toyl C14:0; stearoyl C18:0) were from Sigma Chemical Co. (St. Louis, MO).
Stock solutions of metabolites (except free camitine, which was prepared
in distilled water) were prepared in 100% methanol and kept at room tem-
perature in dark vials under N2. Bovine brain phosphotidylethanolamine
(PE) and phosphatidylserine (PS) were from Avanti Polar Lipids (Binning-
ham, AL). Na2ATPwas purchased from Sigma Chemical Co. Ruthenium red
(Ruthenium III chloride oxide) and CsCl (Johnson Matthey Materials Tech-
nology, Danvers, MA) were purchased from Alpha Products (Andover,
MA). [3H]Ryanodine (60 Ci/mmol) and 45Ca2, (1 Ci/mmol) were from Du
Pont-New England Nuclear (Wilmington, DE).
RESULTS
Stimulation of [3H]ryanodine binding by palmitoyl
carnitine
Ryanodine is an alkaloid that binds with nanomolar affinity
to the open conformational state of the Ca2" channel formed
by a ryanodine receptor tetramer (Carrol et al., 1991; Pessah
and Zimanyi, 1991). The number of high-affinity [3H]ryan-
odine binding sites increases in the presence of ligands that
selectively open the channel (Valdivia et al., 1992b). We
exploited this property of the ryanodine binding site to test
whether palmitoyl carnitine could interact directly with ry-
anodine receptors under the assumption that, by stimulating
gating, palmitoyl carnitine would increase [3H]ryanodine
binding. Fig. 1 shows the effect of palmitoyl carnitine (la-
beled PC), palmitic acid (labeled PA), or free carnitine (la-
beled C) on [3H]ryanodine binding to porcine sarcoplasmic
reticulum. Specific binding in a reference solution at 36°C
without metabolites was 0.48 ± 0.1 pmol/mg. The reference
solution was composed of 7 nM [3H]ryanodine, 0.2 M KCI,
10 ,uM free Ca2+, and 10 mM Na-PIPES (pH 7.2) and was
chosen to ensure that only a small number of receptors would
be tagged such that changes in [3H]ryanodine binding pro-
duced by the modulator in either direction (stimulation or
inhibition) would be noticeable. The total number of [3H]-
ryanodine binding sites estimated at optimal salt concentra-
tion (1 M KCI), Ca2+ (100 ,uM CaCl2), adenine nucleotide
(5 mM ATP), and saturating [3H]ryanodine concentration
(100 nM) was 6.3 ± 0.5 pmol/mg at pH 7.2 and 11.6 ± 2
pmol/mg at optimal pH (pH 8.5). These values agreed well
with previous reports in porcine sarcoplasmic reticulum in
similar solutions (Hawkes et al., 1992). Palmitoyl carnitine
in the range of 5 to 50 ,uM produced an almost linear stim-
ulation of [3H]ryanodine binding that reached 0.76 ± 0.12
pmol/mg at 50 ,M, the highest concentration tested. Neither
palmitic acid nor free carnitine affected [3H]ryanodine bind-
ing, indicating that the stimulatory effect of palmitoyl car-
nitine was specific for the esterified fatty acid. The stimu-
lation of [3H]ryanodine binding was fully reversible, as
demonstrated by binding experiments in palmitoyl carnitine-
pretreated sarcoplasmic reticulum (see Materials and Meth-
ods). Fig. 2 shows that stimulation of [3H]ryanodine binding
by palmitoyl carnitine was observed at all Ca2+ concentra-
tions in the pCa range 6 to 3 and was largest at 100 ,tM free
Ca2 . The Hill plots in Fig. 2B indicated the absence of
changes in Hill coefficients in the presence of palmitoyl car-
nitine in both the stimulatory (nH = 0.8) and inhibitory
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FIGURE 1 Stimulation of [3H]ryanodine binding by palmitoyl carnitine.
Effect ofpalmitoyl camitine (PC, *), free carnitine (C, A), and palmitic acid
(PA, U) on the specific [3H]ryanodine binding to porcine skeletal muscle
sarcoplasmic reticulum. Duplicate samples (40 ,Lg each) were incubated in
0.1 ml of 7 nM [3H]ryanodine, 0.2 M KCI, 10 ,uM Ca2+, and 10 mM Na-
PIPES (pH 7.2) at 36°C for 120 min in the presence of indicated concen-
trations of PC (mean and SD of three determinations); PA (mean of two
determinations); C (mean of two determinations).
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Thus the main effect of palmitoyl carnintine was to increase
the number of high affinity binding sites available for [3H]-
ryanodine without changes in cooperativity of the interaction
of Ca2" or ryanodine. These data and those of Fig. 2 are
consistent with a Ca2+-independent, noncompetitive stimu-
lation of [3H]ryanodine binding and suggested a direct effect
of palmitoyl carnitine on channel gating.
Palmitoyl carnitine-induced release of "Ca2+
from sarcoplasmic reticulum
-7 -6 -5 -4 -3 -2 To determine if the observed changes in [3H]ryanodine bind-
Log [Ca+2Jfree ing activity affected the Ca2+ permeability of sarcoplasmicB reticulum, we measured the "Ca2l content of sarcoplasmic
reticulum exposed to palmitoyl carnitine. In Fig. 4A, 45Ca2+
-1 content as a function of time was measured by rapid filtration
in a reference solution (labeled Mg2+) containing 5 mM
MgCl2 and 1 mM EGTA to set the free Ca2+ to 55 nM.
Nanomolar free Ca2+ and millimolar Mg2+ were chosen so
-2- that 45Ca2+ release in the absence of palmitoyl carnitine
would be minimal (Meissner 1984; Valdivia et al., 1992a).
The results indicated that Ca2+ release in the reference so-
lution was no more than 12% of the original content during
.3 the first 9 s. However, when 50 ,uM palmitoyl carnitine was
-7 -6 -5 -4 -3 -2 added to the reference solution (labeled PC + Mg2+), 45Ca2+
Log [Ca2+]free content decreased in time and settled at approximately 25%
of the original content after 5 s of exposure. Thus the me-
2 Ca2+ dependence of palmitoyl carnitine stimulation of [3H]- tabolite induced a massive release of the stored Ca2+ on a
ne binding. (A) Duplicate samples (40 ,g each) of procine skeletal relatively slow time scale. 45Ca2+ release on the time scalejunctional sarcoplasmic reticulum were incubated with 7nM [3H]- of milliseconds was also investigated and is described in Fig.
ne at 36°C for 120 min in reference solution containing 1 mM EGTA 8. To determine the size of the Ca2+pool mobilized by palm-
212 necessary to reach specified free Ca2 . Specific binding in the itoyl caritine we focused on the steady-state "Ca2+ content(0) and presence (0) of 50 ,M palmitoyl carnitine. (B) Hill rep-
. Tion of the same data. Mean and SD (A) or mean without SD (B) of after prolonged exposure to the metabolite. This was done in
terminations. Fig. 4B, where we simplified the efflux protocol by per-
forming filtrations manually. 45Ca2+ content was measured
by the dilution of a small aliquot of rabbit sarcoplasmic retic-
1.1) phases of the Ca2+ dependence of the ryanodine ulum passively loaded with 45Ca2+ in the reference solution
Dr. This Ca2+ dependence was similar to that produced described above supplemented with the indicated concen-
P (Pessah and Zimanyi, 1991) but differed from that tration of palmitoyl carnitine (labeled PC), palmitic acid (la-
-ed by caffeine, since stimulation of [3H]ryanodine beled PA), or free carnitine (labeled C). Following dilution,
g by the latter compound is observed only at submi- vesicles were retained on nitrocellulose filters and washed as
lar Ca2+ (Valdivia et al., 1991b). described in Materials and Methods. The time of exposure of
xperiments shown Fig. 3A, fixed concentrations of vesicles to the metabolite from the moment of dilution to the
oyl carnitine (50 ,uM) and Ca2+ (10 ,uM) stimulated moment of filtration and wash was timed at a minimum of
anodine binding when the alkaloid was varied in the 5 s and was never more than 10 s. Dose-response curves
Af1 to 60 nM. A double reciprocal representation (Fig. obtained in this manner in rabbit sarcoplasmic reticulum are
dicated a linear relationship in which the slope was shown in Fig. 4B. A similar result in the porcine preparation
sed by the metabolite. The fact that the x-intercepts in is shown in Fig. 7. The 45Ca2+ content in the absence of
sence and absence of palmitoyl carnitine were non- metabolites was 35 ± 4 nmol/mg (n = 7). The lowest con-
al suggested a noncompetitive bisubstrate type of re- centration of palmitoyl carnitine tested (5 ,uM) reduced the
between palmitoyl carnitine and ryanodine. The par- 45Ca2+content to 32 ± 4 nmol/mg (n = 7), a difference that
nes in the Hill representation of Fig. 3C indicated the was statistically significant to a value t 2to.1. The highest
e of changes in Hill coefficients (nH = 1.2). Finally, concentrations tested (50 lM) reduced the 45Ca2, content to
ttchard analysis in the absence and presence of palm- 12 ± 4 nmol/mg (-66% release). The palmitoyl carnitine
arnitine (Fig. 3D) resulted in a significant difference concentration that released 50% of the 45Ca2+content in 5 s(1.6 ± 0.2 versus 2.8 ± 0.3 pmol/mg, respectively) was approximately 16 ,uM. In contrast, neither free fatty acid
in Kd (16 ± 1.8 versus 19.7 ± 2.1 nM, respectively). nor free carnitine in the same concentration range affected
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FIGURE 3 Scatachard analysis of palmi-
toyl camnitine stimulation of [3H]ryanodine
binding. (A) Duplicate samples of porcine
skeletal muscle junctional sarcoplasmic retic-
ulum (40 ,ug each) were incubated for 120
min at 36°C in reference solution with indi-
cated concentrations of [3H]ryanodine in the
absence (0, CONTROL) and presence (@,
PC) of 50 ,uM palmitoyl camitine. (B) Dou-
ble reciprocal representation of the same data.
Fitted lines extrapolated to Kd values of 18
and 33 nM, respectively, for control binding
and binding in the presence of palmitoyl car-
nitine. (C) Hill representation of the same
data. Slope of the fitted lines was 1.2. (D)
Scatchard representation of the same data
yielded apparent Bma,, and Kd values of 1.6 ±
0.2 pmollmg and 16.0 ± 1.8 nM for control
binding and 2.8 ± 0.3 pmol/mg and 19.7 ± 2.1
nM for binding in the presence of palmitoyl
carnitine. Mean and SD (A) or mean without
SD (B, C, D) of four determinations.
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the 45Ca2+ content. Thus, palmitoyl carnitine and not the free
fatty acid nor the esterifying group alone increased the pas-
sive Ca2+ permeability of the sarcoplasmic reticulum.
Although palmitoyl carnitine affected both [3H]ryanodine
binding and 45Ca2' efflux in the same concentration range,
these results did not establish that Ca2' efflux occurred by
activation of the Ca2' release channel. In Fig. 5, we addressed
this question by comparing the effect of well-known acti-
vators and inhibitors of Ca2' release channels on the palm-
itoyl carnitine-stimulated [3H]ryanodine binding (Fig. 5 A)
and the palmitoyl carnitine-induced 45Ca2' efflux (Fig. 5B).
In Fig. 5A, the control corresponded to the nonstimulated
[3H]ryanodine binding at pCa 5, similar to that shown in Fig.
1. In agreement with previous results (Carrol et al., 1991;
Pessah and Zimanyi, 1991; Valdivia et al., 1992) we found
that activators of the channel such as caffeine (30 mM),
adenine nucleotides (e.g., adenylyl (3,'y-methylene)diphos-
phate (AMP-PCP), 3 mM), KCl (0.7 M), or alkaline pH (pH
8.5) stimulated [3H]ryanodine binding, whereas blockers
such as Mg2+ (1 mM), ruthenium red (10 ,uM), millimolar
Ca2, (1 mM), or near-acid pH (pH 6) inhibited [3H]ryanodine
binding. Palmitoyl carnitine (50 ,M) in the presence of each
of the activators (except pH 8.5) increased [3H]ryanodine
binding by an amount equal to or greater than that produced
by palmitoyl carnitine in the reference solution (labeled con-
trol). The lack of stimulation by palmitoyl carnitine at al-
kaline pH could be due to a saturation of the number of
binding sites, since alkaline pH may have increased to nearly
unity the open probability of the entire population of Ca2+
release channels (Ma et al., 1988). On the other hand, palm-
itoyl carnitine was not able to stimulate [3H]ryanodine bind-
ing in the presence of inhibitors such as ruthenium red, mil-
limolar Ca2 , or pH 6. We noticed, however, that in the
presence of Mg2+ there was a small, yet statistically signif-
icant stimulation. Hence, with the exception of millimolar
Mg2+, extreme ligand conditions that generate a strong clo-
sure of the channel abolished the stimulatory effect of palm-
itoyl carnitine. These results strengthened the view that the
interaction of palmitoyl carnitine with ryanodine receptors,
much like that of caffeine and adenine nucleotides, occurred
by modulation of Ca2' release channel gating.
The effect of activators and inhibitors of the Ca2+ release
channel on the 45Ca2+ efflux stimulated by palmitoyl car-
nitine were also consistent with this hypothesis. In Fig. SB,
100% release corresponds to the 45Ca2' released by the ion-
ophore A23187 as described in Materials and Methods. We
designated as control the 45Ca2+ efflux induced by the di-
lution of porcine sarcoplasmic reticulum into a reference so-
lution with a fixed free Ca2+ of -10 ,uM. This resulted in a
-50% reduction of 45Ca2+ content at the end of a 5-s in-
cubation period followed by manual filtration. Two features
suggested that this efflux was mediated by a Ca2+-dependent
activation of ryanodine receptors. First, the open bars of Fig.
SB show that "5Ca2+ release in the reference solution plus 20
,uM ruthenium red (labeled RUTH. RED) or in the presence
of 5 mM Mg2+ without added Ca2+ (labeled Mg2+) was sub-
stantially reduced, to no more than -8% of the total 45Ca2+
content. Second, as will be described later (Fig. 8), ATP dra-
matically increased the rate of 45Ca2+ release measured on a
millisecond time scale. Both the inhibition by ruthenium red
and Mg2+ and the increase in the efflux rate by ATP are
hallmarks of Ca2+-induced Ca2+ release mediated by ryan-
odine receptors. The filled bars of Fig. SB show that palm-
itoyl carnitine produced a small decrease in 45Ca2+ content
(increase in 45Ca2+ release) when added to the control me-
dium but had no effect on the presence of ATP or caffeine.
We interpreted this result to indicate that palmitoyl carnitine
released 45Ca2+ from the same pool as micromolar Ca2 ,
caffeine, and ATP. Thus at sufficiently long times, the loss of
45Ca2+ content produced by a single ligand, i.e., ATP or caf-
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FIGURE 4 45Ca2+ content of sarcoplasmic reticulum exposed to various
concentrations of palmitoyl camitine. (A) Rapid filtration of 45Ca2+ pas-
sively loaded into rabbit skeletal muscle sarcoplasmic reticulum was per-
formed for the indicated times in duplicate samples each of 50 ,ug protein.
Filtration solutions consisted of 5 mM MgCl2, 1 mM EGTA, 150 mM KCI,
50mM MES-Tris (pH 7.2) (Mg2") or 5 mM MgCl2, 1 mM EGTA, 150mM
KCI, 50 mM MES-Tris (pH 7.2) plus 50 ,uM palmitoyl carnitine (PC +
Mg{). (B) Duplicate samples (50 ptg each) of 45Ca2+ passively loaded into
rabbit skeletal muscle sarcoplasmic reticulum were diluted for S s at 36°C
in 5 mM MgCl2, 1 mM EGTA, 150 mM KCI, 50 mM MES-Tris (pH 7.2)
plus indicated concentrations of palmitoyl carnitine (PC, 0), free carnitine
(C, A), palmitic acid (PA, U). (A) Mg2 , PC + Mg2+ (mean and SD of three
to five determinations). (B) PC (mean and SD of six to nine determinations),
C (mean and SD of three determinations), and PA (mean and SD of 3 de-
terminations).
feine, should be the same as that produced by two ligands
acting on the same pool, i.e.,ATP or caffeine plus metabolite.
On the other hand, when palmitoyl carnitine was added in the
presence of inhibitors, there was a partial inhibition by ru-
thenium red, but Mg2+ was unable to inhibit the release in-
duced by the metabolite. Thus palmitoyl carnitine appeared
to override the inhibition of the Ca2+ release channel by Mg2+
but not that produced by ruthenium red.
Taken together, the [3H]ryanodine binding data of Fig. 5A
and 45Ca2+ flux data of Fig. 5B suggest that palmitoyl car-
nitine was unlikely to act as a Ca2+ ionophore. If this were
the case, the releases induced separately by palmitoyl car-
nitine and ryanodine receptor activators (ATP, caffeine)
should have been additive. Consequently, the percentage of
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FIGURE 5 Effect of activators and inhibitors of the Ca2l release channel
on palmitoyl carnitine-induced activation. (A) [3H]ryanodine binding to
duplicate samples (40 ,ug each) of porcine skeletal muscle sarcoplasmic
reticulum was assayed in reference solution (0.2 M KCl, 10mM Na-PIPES,
10 ,uM Ca2+, pH 7.2, and 7 nM [3H]ryanodine) in the absence (O) or pres-
ence (U) of 50 ,uM palmitoyl carnitine. Reference solution was modified to
include activators (caffeine, 30 mM; AMP-PCP, 3 mM; KCl, 0.7 M; pH 8.5)
and inhibitors (ruthenium red, 10 ,uM; Mg2+, 3 mM; pH 6.5) of [3H]ry-
anodine binding. Control [3H]ryanodine binding labeled 100% was 0.5
pmollmg protein. (B) Duplicate samples (50 ,ug each) of 45Ca2+ passively
loaded into porcine skeletal muscle sarcoplasmic reticulum were diluted for
5 s at 36°C in solutions without (a) or with (U) 50 ,uM palmitoyl carnitine.
The compositions of solutions were: control, 6.25 mM EGTA, 6.23 mM
CaC2, 150 mM KCl, 50 mM MES-Tris, pH 7.5; caffeine, 6.25 mM EGTA,
6.23 mM CaCl2, 30 mM caffeine, 150 mM KCl, 50 mM MES-Tris, pH 7.5;
ATP, 6.25 mM EGTA, 6.23 mM CaCl2, 1 mM ATP, 150 mM KCI, 50 mM
MES-Tris, pH 7.5; ruthenium red, 6.25 mM EGTA, 6.23 mM CaCl2, 20 ,uM
ruthenium red, 150 mM KCl, 50 mM MES-Tris, pH 7.5; and Mg2+, 5 mM
MgCl2, 1 mM EGTA, 150 mM KCl, 50 mM MES-Tris, pH 7.5. 45Ca2+
content was 30 ± 4 nmollmg and was taken as 0% release. Bars in (A)
correspond to the mean and SD of three determinations. Bars in (B) cor-
respond to the mean and SD of three to five determinations. Statistical
significance t > to.025 for the difference between the two means (modulator
and modulator + PC) is indicated by asterisks.
45Ca2' released by palmitoyl carnitine in the presence of
activators (when Ca2+ release channels are open) should have
been much larger than the percentage of 45Ca2' released by
palmitoyl carnitine in millimolar Mg2+ and nanomolar Ca2,
(when Ca2+ release channels are closed). Instead, the data
showed that releases in control solution as well as in the
presence of activators, with or without metabolite, were not
statistically different. The most likely explanation for the fact
that palmitoyl carnitine did not increase 45Ca2' release under
-
784 Biophysical Journal
Palmitoyl Carnitine Effect on Ryanodine Receptor
conditions in which [3H]ryanodine binding was significantly
stimulated, such as in the control solution or in the presence
of adenine nucleotide, appears to be that the metabolite spe-
cifically activated 45Ca2" flux in a subpopulation of sarco-
plasmic reticulum vesicles sensitive to ryanodine receptor
ligands, comprising approximately 65% of the internal vol-
ume.
Opening of Ca2+ release channels by palmitoyl
carnitine
If the interaction of palmitoyl carnitine and ryanodine re-
ceptors resulted in a significant activation of the Ca2" release
channel, this should be reflected as an increase in open chan-
nel probability. To confirm this hypothesis, we performed
recordings of Ca2" release channels in planar bilayers using
CsCl as the charge carrier (Coronado et al., 1992). In these
studies we used porcine junctional sarcoplasmic reticulum,
since vesicle-bilayer fusions occurred more readily in this
preparation than in preparations of rabbit skeletal muscle.
Recording solutions were composed of 250 mM cis (cyto-
solic) and 50 mM trans (lumenal) CsCl buffered to pH 7.2.
Continuous records compressed in time before and after cis
addition of 50 ,uM palmitoyl carnitine are shown in Fig. 6A.
In five recordings (see Table 1), open channel probability
(P.) monitored over 80 s increased from 0.028 ± 0.04 during
control to 0.201 ± 0.10 in the presence of palmitoyl car-
nitine. The most significant effect was an increase in the
number of open events with a comparatively longer duration
(Fig. 6B). The increase in activity was quantified in Fig. 6C
as a graph of cumulative PO as a function of recording time.
In this plot, PO was averaged continuously every 5 s for a total
time of 80 s. Each probability was summed to that of the next
A
CONTROL
TABLE I Increase In open probability of Ca2+ release
channels of porcine skeletal muscle by palmitoyl carnitine
Open probability Recording time
(PO) (s) n
Control 0.028 ± 0.04 798 5
50 ,M palmitoyl camitine 0.201 ± 0.10 1124
Control 0.101 184 2
50 ,uM free carnitine 0.088 215
Control 0.059 230 2
50 ,uM palmitic acid 0.054 312
n is the number of recordings, each composed of a control and a test period.
Recording time corresponds to the total time during the n recordings. Open
probability corresponds to the mean (±SD) of n values weighed according
to the recording time.
interval, and the cumulative sum was plotted as a function
of time. Thus, the slope is proportional to the number of open
events per unit time in each condition. From this plot it is
apparent that palmitoyl carnitine produced a constant acti-
vation during the time of exposure, and the activation did not
decay with time. In kinetic terms, activation by palmitoyl
carnitine resulted in an increase in mean open channel du-
ration caused by a shift from mostly short openings to
roughly equal proportion of short and long openings. As
shown in Fig. 6D, a total number of 1272 events collected
during the control period were fit by two exponentials with
time constants of 0.7 ms (T short) and 6 ms (T long) with a
ratio of T short/T long of 16.6. In the presence of 50 ,uM
palmitoyl carnitine, a total of 8221 events collected during
a similar period were fit by time constants of 1 and 5 ms with
a ratio of T short/T long of 4.3. Table 1 shows that in two
separate control recordings in which activity was monitored
B
FIGURE 6 Opening of Ca2l release chan-
nels by palmitoyl carnitine. (A) Recordings
from the same channel before and after the cis
addition of 50 ,uM palmitoyl carnitine at +20
mV. Openings are shown as upward deflec-
tions. (B) A total of 160 s of continuous re-
cordings before and after addition of 50 ,uM
palmitoyl carnitine was divided into 250-ms
intervals. PO in each interval is plotted as a bar
of length 0 to 1. (C)A total of 80 s before and
after the addition of 50 ,uM palmitoyl carnitine
were divided into intervals of 3 s. PO in each
interval was added to that of the previous one,
and the cumulative sum was plotted as a func-
tion of recording time. (D) Number of open
events (normalized) of different durations is
plotted as a function of duration. The number
of fitted events was 1272 (control) and 8221
(after 50 ,uM palmitoyl carnitine). The mean PO
and SD of five determinations are given in
Table 1.
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before and after cis addition of 50 ,uM palmitic acid,
PO was 0.06 and 0.05. Similarly, in two recordings be
after cis addition of 50 ,uM carnitine, average P0 was
0.09. Therefore, palmitic acid and carnitine did no
icantly alter channel activity, which is consistent w
lack of effect on [3H]ryanodine binding and 45Ca2,
Fig. 7A shows the activation of a Ca2' release cha
various concentrations of palmitoyl carnitine. The me
produced a concentration-dependent increase in the
of openings per unit time. In this particular recordi]
was an 8-fold increase in PO from 0.03 in the contro
without palmitoyl camitine to 0.25 in the presence of
palmitoyl carnitine. The effect of palmitoyl carnitine
probability saturated between 50 and 100 ,uM. In FiE
compared the dose-dependent increase in open prc
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(open triangles) with the palmitoyl carnitine-induced 45Ca2+
efflux (filled triangles) in porcine sarcoplasmic reticulum at
room temperature (20-220C). There was a close correspon-
dence between the level of activation of the Ca2+ release
channel and the increase in sarcoplasmic reticulum Ca2, per-
meability. This agreement was considered strong evidence
that the increase in the sarcoplasmic reticulum Ca2+ perme-
ability was generated by a direct opening of the Ca2+ release
channel by palmitoyl carnitine.
Mechanism of activation of the Ca2+ release
channel by palmitoyl carnitine
g.7B we In order to gain insight into the mechanism of channel ac-
bability tivation by palmitoyl carnitine, we compared in Fig. 8 the
kinetics of Ca2" release by palmitoyl carnitine and that oftwo
ligands that directly open the Ca2' release channel, namely
Ca2' and ATP (Ogawa and Ebashi, 1976; Meissner, 1984).
The kinetics of release was resolved by rapid filtration, a
technique that permits the fast replacement of a reference
JC4~ extravesicular solution with a test solution containing an ac-
tivator of interest (Valdivia et al., 1992a). The reference so-
] 25pA lution (labeled Mg2+) contained 5 mM MgCl2 plus 1 mM
ms EGTA (-7 nM final free Ca2+) and was chosen to maintain
the Ca2' release channel in a closed state (Kawano and Coro-
nado, 1991). Test solutions designed to suddenly open the
W*ft channel contained 10 ,uM free Ca2, (labeled Ca2+) or 10 ,uM
free Ca2+ plus 1 mM total ATP (labeled ATP). Palmitoyl
I carnitine (50 ,iM) was delivered in reference solution (la-
beled PC + Mg2+) in order to distinguish this activation from
that by Ca2' and ATP. The combination of the latter two
activators, which open the channel to the highest level
(Kawano and Coronado, 1991), resulted in a release of 67 ±
4% of the Ca2, pool in 200 ms with a t1/2 of less than 20 ms.
Ca2' alone released 49 ± 11% of the pool with a t1/2 of
approximately 40 ms, whereas Mg2+ inhibited release almost
[0.3 * entirely (8 ± 10%). Although Ca2+ and Ca2+ + ATP released
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FIGURE 7 Concentration-dependent activation of the skeletal muscle
Ca2l release channel by palmitoyl camitine. (A) Single-channel recordings
at +20 mV and indicated concentrations of palmitoyl carnitine added to the
cis solution. Traces are from the same channel before and after addition. (B)
Open triangles correspond to 45Ca2+ content of porcine skeletal muscle
sarcoplasmic reticulum after exposure to various palmitoyl camitine con-
centrations at room temperature 20-22°C. Protocol was the same as in Fig.
4. Filled triangles correspond to P. of Ca2' release channels from pig sar-
coplasmic reticulum at the indicated palmitoyl carnitine concentrations.
45Ca2+ content (A) corresponds to the mean and SD of three to five de-
terminations. PO (A) corresponds to the mean and SD of three determina-
tions.
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FIGURE 8 Time course of 45Ca2l release from sarcoplasmic reticulum
induced by 50 ,iM palmitoyl carnitine. Duplicate samples (50 ,g each) of
45Ca2l passively loaded into rabbit skeletal muscle sarcoplasmic reticulum
were fast-filtered for the indicated time in milliseconds. Filtration solutions
were labeled Mg2+ (5 mM MgCl2, 1 mM EGTA, 150 mM KCI, 50 mM
MES-Tris, pH 7.5); PC + Mg2+ (5 mM MgCl2, 1 mM EGTA, 50 ,uM palm-
itoyl carnitine, 150 mM KCI, 50 mM MES-Tris, pH 7.5); Ca2+ (6.25 mM
EGTA, 6.23 mM CaCl2, 150mM KCI, 50 mM MES-Tris, pH 7.5); and ATP
(6.25 mM EGTA, 6.23 mM CaCl2, 1 mM ATP, 150 mM KCI, 50 mM
MES-Tris, pH 7.5). Mean and SD of four determinations.
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different amounts of stored Ca2" at 200 ms, the releases at
5 s were statistically indistinguishable, in either the presence
or absence of palmitoyl carnitine (see Fig. SB). Thus Ca2,
release was comprised of fast and slow phases, in agreement
with many previous publications (Ikemoto et al., 1985;
Calviello and Chiesi, 1989; Meissner, 1984; Brandt et al.,
1992). Palmitoyl carnitine produced a release that was much
slower than that produced by Ca2' and ATP and had a dis-
tinctive lag, in these experiments, of approximately 100 ms.
At 200 ms, the release by palmitoyl carnitine was 25 ± 14%
or about one-third of the efflux at 5 s (see Fig. 4). These
results indicated that the interaction of the ryanodine receptor
and palmitoyl carnitine was inherently slow and did not lead
to an instantaneous activation of the channel.
An important clue about the steps leading to the activation
of the release channel by palmitoyl carnitine was provided
by the results of Fig. 9 in which we tested acyl carnitines
(labeledAC), acyl coenzymeA(labeledAcoA), and free fatty
acids (labeled FA) of saturated hydrocarbon chain length C8
to C18. In these experiments, "5Ca2+-loaded sarcoplasmic
reticulum was exposed to a constant concentration of me-
tabolite (50 ,uM) at 36°C, and the 45Ca2+ content was meas-
ured by manual filtration at the end of a 5-s incubation period.
The data indicated that long-chain acyl carnitines (C14 to C18)
but not medium-chain acyl carnitines (C8 to C12) could in-
duce 45Ca2' release. When carnitine was replaced by coen-
zymeA as the esterifying group, release was enhanced for the
medium-chain fatty acid but drastically inhibited for the
long-chain fatty acids of the series. Hence the esterifying
group may also play a critical role, either by a specific in-
teraction at a receptor site or by changing the solubility or
hydrophobicity of the metabolite. The control experiments
with free fatty acids were equally significant since none of
the free fatty acids in the series could induce 45Ca2+ release.
Hence saturated free fatty acids per se, despite reports to the
contrary (Fletcher et al., 1991), do not increase the sarco-
plasmic reticulum Ca2, permeability. We also tested the un-
saturated oleic (C18:1), linoleic (C18:2), and arachidonic
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FIGURE 9 "5Ca2l content of sarcoplasmic reticulum exposed to acyl car-
nitines and acyl coenzymeA derivatives of various fatty acid chain lengths.
Duplicate samples (50 ,.g each) of 45Ca2l passively loaded into rabbit skel-
etal muscle sarcoplasmic reticulum were diluted for 5 s at 36°C in 5 mM
MgCl2, 1 mM EGTA, 150mM KC1, 50mM MES-Tris (pH 7.2) plus 50 ,uM
acyl carnitine (AC, 0), acyl coenzyme A (ACoA, A), or free fatty acid (FA,
U). 45Ca2+ content after rapid filtration for 2 ms in dilution medium in the
absence of metabolites was 56 ± 4.5 nmol/mg and was taken as 0% release.
Mean and SD of three to seven determinations.
(C20:4) free fatty acids. In our hands, only arachidonic acid
(50 ,uM) induced a Ca2' release significantly different from
controls, amounting to 51 ± 9% (n = 4) of the original
45Ca2+ passively loaded. The results obtained with the car-
nitine and coenzyme A series suggested that the interaction
of palmitoyl carnitine and the ryanodine receptor required a
partitioning of palmitoyl carnitine into the membrane phase
or into a hydrophobic domain of the receptor since the af-
finity of the interaction increased as the fatty acid chain
length increased. On the other hand, the esterifying group
played a critical role in determining the specificity of the
interaction for exclusively long-chain length metabolites, as
in the case of acyl carnitine derivatives, or exclusively
intermediate-chain length metabolites, as in the case of acyl
coenzyme A derivatives.
DISCUSSION
The results of this study indicate that palmitoyl carnitine is
an activator of the Ca2, channel formed by the ryanodine
receptor that directly binds to a site in the channel controlling
gating. This conclusion is consistent with earlier findings in
which palmitoyl carnitine in the range of 1 to 10,M reduced
the net Ca2+ sequestered into skeletal muscle sarcoplasmic
reticulum by the Ca2, pump (Messineo et al., 1982). The
activation of ryanodine receptors by palmitoyl carnitine did
not depend on the animal species and was quantitatively sim-
ilar in porcine, rabbit, or frog (not shown) skeletal muscle
sarcoplasmic reticulum. Although other studies have shown
that palmitoyl carnitine inhibits numerous transport proteins,
these disturbances occur at metabolite concentrations in the
range of 100 to 1000 ,uM (Corr et al., 1984), which is much
higher than those used here to activate the skeletal ryanodine
receptor. In recent studies in isolated ventricular myocytes
(Meszaros and Pappano, 1990; Wu and Corr, 1992), low con-
centration of palmitoyl carnitine in the range of 1 to 10 ,uM
produced an inhibition of Ca2, currents, a reduction in the
duration of action potentials, and afterdepolarizations result-
ing in triggered activity that were consistent with Ca2, over-
loading of cells. The latter could have occurred by an increase
in the Ca2+ permeability of the cardiac sarcoplasmic retic-
ulum. However, we are not sure at this point if cardiac
ryanodine receptors may also be activated by palmitoyl
carnitine, inasmuch as we did not detect changes in
[3H]ryanodine binding in the heart induced by this metabolite
(El-Hayek et al., 1992).
Potential roles of palmitoyl carnitine as a cellular
modulator of Ca2+ release channels
Palmitoyl carnitine increased the sarcoplasmic reticulum
Ca2+ permeability in nanomolar free Ca2+ and millimolar
Mg2+, which are conditions known to prevail in the cyto-
plasm of resting muscle cells (Maughan and Godt, 1989).
This suggests that there is no major impediment for the Ca2+-
releasing action of these metabolites in situ. However, there
is little information on the intracellular concentrations of
0 AP MP
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these metabolites that would allow us to compare the sen-
sitivity of the Ca2' release channel to in situ concentrations
of acyl carnitines under various metabolic conditions.
Plasma concentrations of long-chain acyl carnitines in nor-
mal fed individuals are in the range of 2 to 4 ,uM (Deufel,
1990). Cytosolic concentrations may hence be higher be-
cause the synthesis of palmitoyl carnitine is localized pri-
marily to the inner surface of the outer mitochondrial mem-
brane (Murthy et al., 1987; Scholte et al., 1990). It is thus
plausible that a cytosolic pool of acyl carnitines may be con-
stantly in contact with the sarcoplasmic reticulum, producing
a "chronic" stimulation of ryanodine receptors in situ, albeit
to a low open probability.
The possibility that palmitoyl carnitine may always be in
contact with the sarcoplasmic reticulum lends itself to several
speculations about the potential role of palmitoyl carnitine as
a modulator of intracellular Ca2+. For example, a small Ca2,
leak from the sarcoplasmic reticulum induced by physio-
logical concentrations of palmitoyl carnitine could influence
the resting cytosolic Ca2' and serve to bring the Ca2' release
channel to a threshold for activation by voltage or other sig-
nals that control the Ca2, permeability of the sarcoplasmic
reticulum (Martonosi, 1984). By the same token, palmitoyl
carnitine and perhaps other acyl carnitines and acyl coen-
zyme A derivatives may be utilized by skeletal muscle cells
to compensate for the severe Mg2+ inhibition of Ca2' release
channels (Kawano and Coronado, 1991) which would oth-
erwise leave the intracellular Ca2+ stores of skeletal muscle
cells unresponsive to cytosolic ligands. It is also of interest
to consider roles related to the increase in acyl carnitine pro-
duction and breakdown that occurs during exercise (Harris
and Foster, 1990). For example, an increased sarcoplasmic
reticulum Ca2+ permeability driven by a sudden increase in
palmitoyl carnitine may lead to sarcoplasmic reticulum Ca2+
depletion that could contribute to muscle fatigue (O'Brien et
al., 1991). Likewise, the increase in acyl carnitine production
that occurs in working skeletal muscle could set in motion
a positive feedback mechanism whereby the Ca2' released
from the sarcoplasmic reticulum by palmitoyl carnitine could
activate Ca2+-dependent mitochondrial dehydrogenases
(McCormack et al., 1990), which in turn would stimulate
(3-oxidation and further metabolic demand for palmitoyl
carnitine.
Implications for pathophysiology of carnitine
palmitoyl transferase 11 deficiency
Plasma levels of long-chain acyl carnitines are significantly
higher in individuals with carnitine palmitoyl transferase II
deficiency (Hoppel et al., 1980). In a particular individual,
the plasma concentration of long-chain acyl carnitines in-
creased from 14 ,uM in the fed state to 22 ,uM under fasting
(Hoppel et al., 1980). At these concentrations, our study (Fig.
4) showed that palmitoyl carnitine produced a significant loss
(-30-50%) of sarcoplasmic reticulum Ca2+. Thus, in patho-
logic conditions leading to the accumulation of palmitoyl
carnitine, such as in carnitine palmitoyl transferase II defi-
ciency, a severe deregulation of intracellular Ca2+ will almost
certainly occur. The loss of sarcoplasmic reticulum Ca2, in-
duced by palmitoyl camitine is an observation that may help
to resolve dilemmas first noted in the original descriptions of
carnitine myopathy and carnitine palmitoyl transferase II de-
ficient myopathy (DiMauro and DiMauro, 1973; Engel and
Angelini, 1973). Both are defects of long-chain fatty acid
metabolism, yet as reviewed by Siliprandi et al. (1990), the
signs and symptoms are quite different. Progressive muscle
weakness, exercise intolerance, and massive accumulation of
triglycerides in type I skeletal muscle fibers are characteristic
of carnitine-deficient myopathy, whereas the primary fea-
tures of carnitine palmitoyl transferase II deficiency are re-
current episodes of muscle necrosis, and myoglobinuria in-
duced by fasting, prolonged exercise, and intercurrent
illness. We propose that palmitoyl carnitine accumulation in
carnitine palmitoyl transferase II deficiency leads to severe
deregulation of sarcoplasmic reticulum Ca2' release and con-
sequent muscle destruction under conditions of increased
metabolic demand. The latter may not occur in carnitine-
deficient myopathy because palmitoyl carnitine is not ele-
vated in this disorder due to a reduction in the muscle levels
of free carnitine (Siliprandi et al., 1990).
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